Clearside Biomedical

CLSD

CLSD Clearside Biomedical NASDAQ
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Financials
    News
    Filings
    Profile
    CLSD Chart
    See on advanced chart >

    About

    Clearside Biomedical, Inc.,is a late-stage clinical biopharmaceutical company developing first-in-class drug therapies to treat blinding diseases of the eye. The Company's current product candidates focus on diseases affecting the retina and choroid,...
    • Highlight
      A company developing opthalmic therapeutic products
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      06/02/2016
    • Established Date
      05/26/2011
    • Full-time Employees
      30
    • Address
      900 North Point Parkway Suite 200 Alpharetta GA 30005
    • Tel
      1-678-2703631
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock